$HPAI
Helport AI Ltd Stock $hpai

$hpai Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 20-F Financial Statement

#000121390024092865 Filed on October 31, 2024

Income Statement

Concept	2024	2023 Q2
Revenue	$29.58M	$0.00
YoY Change
Cost Of Revenue	$11.00M
YoY Change	125.24%
Gross Profit	$18.58M
YoY Change	136.79%
Gross Profit Margin	62.81%
Selling, General & Admin	$5.077M	$330.0K
YoY Change	114.66%	73.68%
% of Gross Profit	27.33%
Research & Development	$4.303M
YoY Change	1046.34%
% of Gross Profit	23.16%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$9.381M	$330.0K
YoY Change	296.6%	73.68%
Operating Profit	$9.197M
YoY Change	58.75%
Interest Expense		$4.260M
YoY Change		-21.55%
% of Operating Profit
Other Income/Expense, Net	$226.7K
YoY Change	2756.77%
Pretax Income	$8.971M	$4.620M
YoY Change	25.99%	-11.83%
Income Tax	$1.602M
% Of Pretax Income	17.86%
Net Earnings	$7.369M	$4.620M
YoY Change	3.49%	-11.83%
Net Earnings / Revenue	24.92%
Basic Earnings Per Share	$47.24K
Diluted Earnings Per Share	$47.24K	$0.16
COMMON SHARES
Basic Shares Outstanding	156.0 shares
Diluted Shares Outstanding	156.0 shares

Balance Sheet

Concept	2024 Q2	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments		$0.00
YoY Change		-100.0%
Cash & Equivalents	$2.581M	$142.4K
Short-Term Investments
Other Short-Term Assets		$100.0K
YoY Change		-75.0%
Inventory
Prepaid Expenses	$27.40K
Receivables	$21.31M	$14.55M
Other Receivables
Total Short-Term Assets	$24.75M	$200.0K
YoY Change	12277.33%	-81.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$2.426M	$4.083M
YoY Change	-40.6%
Long-Term Investments		$241.5M
YoY Change		3.87%
Other Assets
YoY Change
Total Long-Term Assets	$2.426M	$241.4M
YoY Change	-99.0%	3.78%
TOTAL ASSETS
Total Short-Term Assets	$24.75M	$200.0K
Total Long-Term Assets	$2.426M	$241.4M
Total Assets	$27.18M	$241.6M
YoY Change	-88.75%	3.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$284.1K	$0.00
YoY Change
Accrued Expenses		$200.0K
YoY Change		100.0%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$14.13M	$200.0K
YoY Change	6963.58%	100.0%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$600.0K
YoY Change		-95.24%
Total Long-Term Liabilities		$600.0K
YoY Change		-95.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$14.13M	$200.0K
Total Long-Term Liabilities		$600.0K
Total Liabilities	$14.13M	$800.0K
YoY Change	1665.89%	-93.7%
SHAREHOLDERS EQUITY
Retained Earnings	$13.05M	$5.677M
YoY Change	129.82%
Common Stock	$7.712K	$7.712K
YoY Change	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$13.05M	$240.8M
YoY Change
Total Liabilities & Shareholders Equity	$27.18M	$241.6M
YoY Change	-88.75%	3.38%

Cashflow Statement

Concept	2024	2023 Q2
OPERATING ACTIVITIES
Net Income	$7.369M	$4.620M
YoY Change	3.49%	-11.83%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$5.034M	-$270.0K
YoY Change	-387.34%	92.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$7.411M
YoY Change	-105.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$4.770M
YoY Change	-103.73%
NET CHANGE
Cash From Operating Activities	$5.034M	-270.0K
Cash From Investing Activities	-$7.411M
Cash From Financing Activities	$4.770M
Net Change In Cash	$2.439M	-270.0K
YoY Change	-1712.57%	92.86%
FREE CASH FLOW
Cash From Operating Activities	$5.034M	-$270.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Document Type DocumentType	20-F
CY2024	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2024	dei	Entity Registrant Name EntityRegistrantName	Helport AI Limited
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D8
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	9 Temasek Boulevard #07-00
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suntec Tower Two
CY2024	dei	Entity Address Country EntityAddressCountry	SG
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Singapore
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	038989
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	ecd	Insider Trd Policies Proc Adopted Flag InsiderTrdPoliciesProcAdoptedFlag	true
CY2024	dei	Auditor Firm AuditorFirmId	6907
CY2024	dei	Auditor Name AuditorName	Enrome LLP
CY2024	dei	Auditor Location AuditorLocation	Singapore
CY2024Q2	us-gaap	Cash Cash	2581086	usd
CY2023Q2	us-gaap	Cash Cash	142401	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21313735	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14545921	usd
CY2024Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	817871	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41966	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	24754658	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	14688322	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2425694	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4083333	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	2425694	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	4083333	usd
CY2024Q2	us-gaap	Assets Assets	27180352	usd
CY2023Q2	us-gaap	Assets Assets	18771655	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	284067	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	10158729	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2724998	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	1123065	usd
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	4889074	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5263239	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1212985	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	14127154	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	13087576	usd
CY2024Q2	us-gaap	Liabilities Liabilities	14127154	usd
CY2023Q2	us-gaap	Liabilities Liabilities	13087576	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000	shares
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	156	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	156	shares
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	156	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	156	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7556	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7556	usd
CY2024Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	156	usd
CY2023Q2	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	156	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	13045642	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	5676523	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	13053198	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5684079	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	27180352	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18771655	usd
CY2024	us-gaap	Revenues Revenues	29575625	usd
CY2023	us-gaap	Revenues Revenues	12728313	usd
CY2022	us-gaap	Revenues Revenues	2667914	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	10998011	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	4882792	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	1246701	usd
CY2024	us-gaap	Gross Profit GrossProfit	18577614	usd
CY2023	us-gaap	Gross Profit GrossProfit	7845521	usd
CY2022	us-gaap	Gross Profit GrossProfit	1421213	usd
CY2024	us-gaap	Selling Expense SellingExpense	97984	usd
CY2023	us-gaap	Selling Expense SellingExpense	50830	usd
CY2022	us-gaap	Selling Expense SellingExpense	99817	usd
CY2024	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4979382	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1625887	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	340625	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4303490	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	375410	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	9380856	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2052127	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	440442	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	9196758	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	5793394	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	980771	usd
CY2024	us-gaap	Other Expenses OtherExpenses	226713	usd
CY2023	us-gaap	Other Expenses OtherExpenses	7936	usd
CY2022	us-gaap	Other Expenses OtherExpenses	5894	usd
CY2024	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1007	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8971052	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5785458	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	974877	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1601933	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	970755	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	152917	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7369119	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4814703	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	821960	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	7369119	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	4814703	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	821960	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	47238
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	30863
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5269
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	47238
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	30863
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5269
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	47416	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	821960	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	869376	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4814703	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	5684079	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7369119	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	13053198	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7369119	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4814703	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	821960	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2352639	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2333334	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	583333	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6813674	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12079780	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2463761	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	41966	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3158729	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2547916	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	610813	usd
CY2024	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	21640	usd
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	7626	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	16450	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3702668	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	951932	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	194508	usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1601933	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	970148	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	152917	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5033630	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-454121	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-83780	usd
CY2024	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	7410933	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-7410933	usd
CY2024	hpai	Payment For Listing Costs PaymentForListingCosts	817871	usd
CY2024	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4889074	usd
CY2024	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	977156	usd
CY2023	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	66545	usd
CY2024	hpai	Repayment Of Loan From A Third Party RepaymentOfLoanFromAThirdParty	629570	usd
CY2024	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	354977	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	569059	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	196388	usd
CY2024	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	3638	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	45102	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	114465	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4770128	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	590502	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81923	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	45860	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2380	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2438685	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	134001	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1857	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142401	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8400	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10257	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2581086	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142401	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8400	usd
CY2024	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	355000000	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" width="100%"><tr style="vertical-align: top"> <td style="text-align: justify; width: 0"></td><td style="text-align: justify; width: 0.25in"><i>(c)</i></td><td style="text-align: justify"><i>Use of estimates</i></td></tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The preparation of the combined financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related disclosures of contingent assets and liabilities at the balance sheet date, and the reported revenues and expenses during the reported periods in the combined financial statements and accompanying notes. Significant accounting estimates include, but not limited to allowance for doubtful accounts and useful lives and impairment of long-lived assets. Changes in facts and circumstances may result in revised estimates. Actual results could differ from those estimates, and as such, differences may be material to the combined financial statements.</p>
CY2024Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	817871	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2581086	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142401	usd
CY2024	hpai	Voting Interest Percentage VotingInterestPercentage	0.10	pure
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	29575625	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12728313	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2667914	usd
CY2024	hpai	Unrecognized Tax UnrecognizedTax	P12M
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21313735	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14545921	usd
CY2024Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	21313735	usd
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	14545921	usd
CY2024	hpai	Accounts Receivable Percentage AccountsReceivablePercentage	0.5281	pure
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	27396	usd
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	13198	usd
CY2024Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1372	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	41966	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7695000	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5269306	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2916667	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2425694	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4083333	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2352639	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2333334	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	583333	usd
CY2024Q2	hpai	Payable To Third Parties PayableToThirdParties	3793161	usd
CY2023Q2	hpai	Payable To Third Parties PayableToThirdParties	297700	usd
CY2024Q2	hpai	Value Added Tax Payables ValueAddedTaxPayables	1333470	usd
CY2023Q2	hpai	Value Added Tax Payables ValueAddedTaxPayables	909710	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	95326	usd
CY2024Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	41282	usd
CY2023Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	5575	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	5263239	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	1212985	usd
CY2024	hpai	Value Added Tax Rate Percentage ValueAddedTaxRatePercentage	0.06	pure
CY2024Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	4889074	usd
CY2024Q2	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2000000	usd
CY2024Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0	pure
CY2024Q2	us-gaap	Line Of Credit LineOfCredit	84991	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1601933	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	970755	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	152917	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1601933	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	970755	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	152917	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8971052	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5785458	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	974877	usd
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1525079	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	983528	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	165729	usd
CY2024	hpai	Effective Income Tax Rate Reconciliation Impact Of Different Tax Rates In Other Jurisdictions EffectiveIncomeTaxRateReconciliationImpactOfDifferentTaxRatesInOtherJurisdictions	95670	usd
CY2024	hpai	Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRate	-18816	usd
CY2023	hpai	Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRate	-12773	usd
CY2022	hpai	Effective Income Tax Rate Reconciliation Effect Of Preferential Tax Rate EffectiveIncomeTaxRateReconciliationEffectOfPreferentialTaxRate	-12812	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1601933	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	970755	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	152917	usd
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	156	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2024	us-gaap	Net Income Loss NetIncomeLoss	7369119	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	4814703	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	821960	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	156	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	156	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	47238
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	30863
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	5269
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	47238
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	30863
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	5269
CY2024	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	355000000	usd
CY2024	hpai	Accounts Receivable Percentage AccountsReceivablePercentage	0.5281	pure
CY2023Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent		usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023	hpai	Payment For Listing Costs PaymentForListingCosts		usd
CY2022	hpai	Payment For Listing Costs PaymentForListingCosts		usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
CY2023	hpai	Repayment Of Loan From A Third Party RepaymentOfLoanFromAThirdParty		usd
CY2022	hpai	Repayment Of Loan From A Third Party RepaymentOfLoanFromAThirdParty		usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent		usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent		usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent		usd
CY2023Q2	us-gaap	Interest Payable Current InterestPayableCurrent		usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	hpai	Effective Income Tax Rate Reconciliation Impact Of Different Tax Rates In Other Jurisdictions EffectiveIncomeTaxRateReconciliationImpactOfDifferentTaxRatesInOtherJurisdictions		usd
CY2022	hpai	Effective Income Tax Rate Reconciliation Impact Of Different Tax Rates In Other Jurisdictions EffectiveIncomeTaxRateReconciliationImpactOfDifferentTaxRatesInOtherJurisdictions		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0002001699
CY2024	dei	Entity File Number EntityFileNumber	000-000000

Files In Submission

Name	View Source	Status
0001213900-24-092865-index-headers.html	Edgar Link	pending
0001213900-24-092865-index.html	Edgar Link	pending
0001213900-24-092865.txt	Edgar Link	pending
0001213900-24-092865-xbrl.zip	Edgar Link	pending
ea0219121-20f_helport.htm	Edgar Link	pending
ea021912101ex11-1_helport.htm	Edgar Link	pending
ea021912101ex11-2_helport.htm	Edgar Link	pending
ea021912101ex12-1_helport.htm	Edgar Link	pending
ea021912101ex12-2_helport.htm	Edgar Link	pending
ea021912101ex13-1_helport.htm	Edgar Link	pending
ea021912101ex13-2_helport.htm	Edgar Link	pending
ea021912101ex15-1_helport.htm	Edgar Link	pending
ea021912101ex2-3_helport.htm	Edgar Link	pending
ea021912101ex97-1_helport.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
hpai-20240630.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
hpai-20240630_cal.xml	Edgar Link	unprocessable
hpai-20240630_def.xml	Edgar Link	unprocessable
hpai-20240630_lab.xml	Edgar Link	unprocessable
hpai-20240630_pre.xml	Edgar Link	unprocessable
ea0219121-20f_helport_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HPAI
Helport AI Ltd Stock $hpai

2024 Q2 Form 20-F Financial Statement

#000121390024092865 Filed on October 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HPAI Helport AI Ltd Stock $hpai

2024 Q2 Form 20-F Financial Statement

#000121390024092865 Filed on October 31, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HPAI
Helport AI Ltd Stock $hpai